EUS-guided Fine Needle Aspiration (EUS-FNA) Versus EUS-guided Fine Needle Biopsy (EUS-FNB) for Diagnosis of Subepithelial Tumors
NCT ID: NCT02943837
Last Updated: 2021-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2016-10-01
2016-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To compare the diagnostic accuracy of EUS-FNA and EUS-FNB.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Accuracy of SurePath™ in EUS-FNA
NCT05394129
The Use of FNA and FNB in the Optimization of EUS-assisted Tissue Sampling
NCT02360839
EUS-guided Fine Needle Aspiration (FNA) With and Without the Use of a Stylet
NCT01316614
A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques
NCT03674710
Comparison of EUS-Guided Fine Needle Aspiration Technique
NCT01923883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EUS-FNA
Device: 22G FNA needle
Device: 22G FNA needle
EUS-FNB
Device: 20G FNB needle
Device: 20G FNB needle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Device: 22G FNA needle
Device: 20G FNB needle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypoechoic lesion including 4th layer on EUS
Exclusion Criteria
* bleeding or rupture of SET
* platelet count \<50,000 or prothrombin time INR \> 1.3
19 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kee Don Choi
Associate professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCSMT 001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.